Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children

Objective: To analyze the clinical characteristics of newly treated high-risk group neuroblastoma (NB) patients with bone marrow metastasis and to explore the prognostic factors. Methods: The clinical features (sex, age, stage, risk group, pathological type, metastatic site, etc.) of 203 newly treat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 57(2019), 11 vom: 02. Nov., Seite 863-869
1. Verfasser: Fan, H J (VerfasserIn)
Weitere Verfasser: Huang, C, Su, Y, Wang, X D, Zhou, Y C, Duan, C, Zhao, W, Zhao, Q, Jin, M, Ma, X L
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Journal Article Bone marrow Child Neuroblastoma Prognosis
LEADER 01000caa a22002652c 4500
001 NLM302703446
003 DE-627
005 20250226051813.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.issn.0578-1310.2019.11.009  |2 doi 
028 5 2 |a pubmed25n1008.xml 
035 |a (DE-627)NLM302703446 
035 |a (NLM)31665841 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Fan, H J  |e verfasserin  |4 aut 
245 1 0 |a Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 12.11.2019 
500 |a Date Revised 08.01.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To analyze the clinical characteristics of newly treated high-risk group neuroblastoma (NB) patients with bone marrow metastasis and to explore the prognostic factors. Methods: The clinical features (sex, age, stage, risk group, pathological type, metastatic site, etc.) of 203 newly treated high-risk NB patients with bone marrow metastasis admitted to Hematology Oncology Center, Beijing Children's Hospital from January 2007 to December 2016 were analyzed retrospectively. There were 118 males (58.1%) and 85 females (41.9%). Kaplan-Meier method was used for survival analysis and Cox regression was used to analyze the prognostic factors. Results: The age at onset of the 203 patients was 41 months (9-147 months). The metastatic sites at diagnosis were as follows: bone in 195 cases (96.1%), distant lymph nodes in 104 cases (51.2%), skull and endomeninx in 61 cases (30.0%), orbit in 30 cases (14.8%), pleura in 16 cases (7.9%), liver in 13 cases(6.4%), canalis spinalis in 13 cases (6.4%), other sites in 11 cases (5.4%) and skin and soft tissue in 10 cases (4.9%). In all, 194 cases were enrolled for prognostic analysis. The follow-up time was 36 months (1 day-138 months) , and the 5-years event free survival (EFS) and overall survival (OS) were 36.1% and 39.7%, respectively. A total of 118 patients (60.8%) had events (first relapse or death) with the time to event occurrence was 15 months (1 day-72 months), whereas 112 patients (57.7%) died with the event occurrence to death time was 3 months (1 day-21 months). There was no significant difference in 5-years OS between radiotherapy group and non-radiotherapy group (42.3% vs. 38.3%, χ(2)=3.671, P=0.055). The 5-years OS in transplantation group was significantly better than the non-transplantation group (44.3% vs. 35.5%, χ(2)=8.878, P=0.003), and the radiotherapy combined transplantation group also had a better 5-years OS rate than the non-radiotherapy combined transplantation group (45.8% vs. 37.3%, χ(2)=5.945, P=0.015). Univariate survival analysis showed lactate dehydrogenase ≥ 1 500 U/L, the amplification of MYCN, the metastatic sites of orbit, canalis spinalis and pleura were associated with poor prognosis of newly diagnosed high-risk NB patients (χ(2)=21.064, 13.601, 3.998, 6.183, 15.307, all P<0.05). The amplification of MYCN and the metastatic sites of pleura were risk factors for prognosis of newly diagnosed high-risk NB patients by Cox regression models (HR=1.896,1.100, 95%CI: 1.113-3.231, 1.020-1.187, both P<0.05). Conclusions: The prognosis is unfavorable in high-risk group NB patients with BM metastasis. Radiotherapy combined with transplantation can further improve the prognosis of these patients. The amplification of MYCN and the metastatic sites of pleura were the poor prognostic factors for high-risk NB patients with bone marrow metastasis 
650 4 |a Journal Article 
650 4 |a Bone marrow 
650 4 |a Child 
650 4 |a Neuroblastoma 
650 4 |a Prognosis 
700 1 |a Huang, C  |e verfasserin  |4 aut 
700 1 |a Su, Y  |e verfasserin  |4 aut 
700 1 |a Wang, X D  |e verfasserin  |4 aut 
700 1 |a Zhou, Y C  |e verfasserin  |4 aut 
700 1 |a Duan, C  |e verfasserin  |4 aut 
700 1 |a Zhao, W  |e verfasserin  |4 aut 
700 1 |a Zhao, Q  |e verfasserin  |4 aut 
700 1 |a Jin, M  |e verfasserin  |4 aut 
700 1 |a Ma, X L  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 57(2019), 11 vom: 02. Nov., Seite 863-869  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:57  |g year:2019  |g number:11  |g day:02  |g month:11  |g pages:863-869 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2019.11.009  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 57  |j 2019  |e 11  |b 02  |c 11  |h 863-869